Fig. 2From: New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of lifeSalivary secretion after administration of pilocarpine solution to individual patients with Sjӧgren’s syndrome. Average 163 ± 381%, n = 24Back to article page